How Cancer Circumvents the Immune System

Share this post on:

LIVE Webinar

Monday, January 10, 2022
2:30 – 4:00 PM Eastern Time

Register Now

The immune system normally identifies and eliminates cancer cells prior to tumor formation. However, cancer cells can induce inhibitory mechanisms that limit antitumor immune activity, allowing for disease progression. In this webinar brought to you by The Scientist and Bio-Techne, Dario Vignali and Peter Westcott will discuss the tug-of-war between cancer cells and the immune system, how cancer cells evade immune cells, and what can be done to circumvent or attenuate these mechanisms for therapeutic purposes.

Topics to be covered

  • Understanding immune inhibitory mechanisms in cancer
  • Modeling T-cell dysfunction in colon cancer

Register Now

Meet the Speakers:

Dario A. Vignali, PhD
Frank Dixon Chair in Cancer Immunology
Vice Chair and Distinguished Professor of Immunology
Director, Cancer Immunology Training Program
Department of Immunology, School of Medicine
University of Pittsburgh

Peter Westcott, PhD
Postdoctoral Scientist
David H. Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology

Leave a Reply

Your email address will not be published. Required fields are marked *